Theodore Saad, MD
Nephrology · Newark, DENPI 1417943994
Payments from drug & device makers
Across 260 payments — averaging $2677.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$192K
- Cook Research Incorporated$147K
- Merit Medical Systems Inc$95K
- Akebia Therapeutics Inc$73K
- Boehringer Ingelheim$58K
- Vertex$54K
- plus $77K from 31 others
Across 2 payments — averaging $584.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Cook Research Incorporated$1K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 12 | $192,111 |
| Cook Research Incorporated | 8 | $147,123 |
| Merit Medical Systems Inc | 9 | $94,676 |
| Akebia Therapeutics Inc | 69 | $72,904 |
| Boehringer Ingelheim | 10 | $58,453 |
| Vertex | 3 | $54,055 |
| CSL Behring | 27 | $32,181 |
| AstraZeneca | 9 | $18,423 |
| Bard Peripheral Vascular, Inc. | 20 | $13,928 |
| Calliditas Therapeutics US Inc. | 3 | $4,375 |
| W. L. Gore & Associates, Inc. | 7 | $3,167 |
| Boehringer Ingelheim Limited | 3 | $2,000 |
| Medtronic | 10 | $1,053 |
| Amgen(2 entities) | 13 | $357 |
| Otsuka America Pharmaceutical, Inc. | 7 | $202 |
| Travere Therapeutics, Inc. | 4 | $165 |
| Fresenius USA Marketing, Inc. | 9 | $152 |
| Boston Scientific | 8 | $152 |
| Nxstage Medical, Inc. | 2 | $130 |
| Mallinckrodt Hospital Products Inc. | 4 | $103 |
| Venturemed Group, Inc. | 1 | $85 |
| Daiichi Sankyo Inc. | 3 | $61 |
| Inari Medical, Inc. | 2 | $45 |
| Vifor Pharma, Inc. | 2 | $44 |
| Bayer | 2 | $33 |
| Kyowa Kirin, Inc. | 1 | $29 |
| AMAG Pharmaceuticals, Inc. | 2 | $28 |
| Gilead | 1 | $27 |
| Angiodynamics, Inc. | 1 | $24 |
| Terumo Medical Corporation | 1 | $17 |
| Ardelyx, Inc. | 1 | $16 |
| Mallinckrodt Enterprises LLC | 1 | $16 |
| GSK | 1 | $15 |
| Sanofi | 1 | $14 |
| OPKO Pharmaceuticals, LLC | 1 | $11 |
| Cook Medical LLC | 1 | $10 |
| Boehringer Ingelheim International GmbH | 1 | $1 |
How this compares
$696,184 in reported general payments places this provider in the 95th percentile of 49 nephrology providers in Delaware.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other nephrology in Newark
- Prayus TailorNewark$127K
- William DahmsNewark$94K
- Nealanjon DasNewark$6K
- Manthodi FaisalNewark$6K
- Piyaporn ApivatanagulNewark$5K
- Lindsey SlaterNewark$4K
- Christopher CanfieldNewark$3K
- Farhana ChowdhuryNewark$3K
- Feroz Abubacker KaniyamparambilNewark$3K
- Carlos MachadoNewark$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.